These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3585612)

  • 1. Absorption characteristics of once-a-day slow-release theophylline preparation in children with asthma.
    Pedersen S; Steffensen G
    J Pediatr; 1987 Jun; 110(6):953-9. PubMed ID: 3585612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.
    Hendeles L; Iafrate RP; Weinberger M
    Clin Pharmacokinet; 1984; 9(2):95-135. PubMed ID: 6370542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady-state evaluation of twice-a-day dosing of a new sustained-release theophylline preparation for young children.
    Welch MJ; Kemp JP; Orgel HA; Meltzer EO
    J Asthma; 1985; 22(5):249-52. PubMed ID: 4055657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theophylline absorption in young asthmatic children receiving sustained-release formulations.
    Haltom JR; Szefler SJ
    J Pediatr; 1985 Nov; 107(5):805-10. PubMed ID: 4056986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Food induced changes in theophylline absorption from a once-a-day theophylline product.
    Steffensen G; Pedersen S
    Br J Clin Pharmacol; 1986 Nov; 22(5):571-7. PubMed ID: 3790404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of a slow-release theophylline capsule given twice daily to preschool children with chronic asthma: comparison with liquid theophylline.
    Sallent J; Hill M; Stecenko A; McKenzie M; Hendeles L
    Pediatrics; 1988 Jan; 81(1):116-20. PubMed ID: 3336577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theophylline levels after single daily and divided dosing of a once-a-day theophylline preparation in asthmatic children.
    Boner AL; Sette L; Vallone G; Plebani M; Messori A
    Ann Allergy; 1989 Feb; 62(2):149-53. PubMed ID: 2919803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theophylline QID, TID, BID and now QD? A report on 24-hour dosing with slow-release theophylline formulations with emphasis on analyses of data used to obtain Food and Drug Administration approval for Theo-24.
    Weinberger MM
    Pharmacotherapy; 1984; 4(4):181-98. PubMed ID: 6483637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of formulation and dosing interval to fluctuation of serum theophylline concentration in children with chronic asthma.
    Weinberger M; Hendeles L; Wong L
    J Pediatr; 1981 Jul; 99(1):145-52. PubMed ID: 7252652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Food and fasting absorption of a single dose of a sustained release theophylline sprinkle formulation in children.
    Pedersen S; Steffensen G
    Allergy; 1986 Jan; 41(1):46-50. PubMed ID: 3963315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratic absorption of a slow-release theophylline sprinkle product.
    Pedersen S; Møller-Petersen J
    Pediatrics; 1984 Oct; 74(4):534-8. PubMed ID: 6483520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of food on the absorption rate and bioavailability of a sustained release theophylline preparation.
    Pedersen S; Moeller-Petersen J
    Allergy; 1982 Oct; 37(7):531-4. PubMed ID: 7181050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theophylline product and dosing interval selection for chronic asthma.
    Hendeles L; Weinberger M
    J Allergy Clin Immunol; 1985 Aug; 76(2 Pt 2):285-91. PubMed ID: 4019956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relation of product formulation to absorption of oral theophylline.
    Weinberger M; Hendeles L; Bighley L
    N Engl J Med; 1978 Oct; 299(16):852-7. PubMed ID: 692577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability and diurnal variation in absorption of sustained release theophylline in asthmatic children.
    Coulthard KP; Birkett DJ; Lines DR; Grgurinovich N; Grygiel JJ
    Eur J Clin Pharmacol; 1983; 25(5):667-72. PubMed ID: 6686557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of a sustained-release theophylline preparation in infants and preschool children with asthma.
    Isles AF; Newth CJ
    J Allergy Clin Immunol; 1985 Mar; 75(3):377-81. PubMed ID: 3973312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady state pharmacokinetics, metabolism and pharmacodynamics of theophylline in children after unequal twice-daily dosing of a new sustained-release formulation.
    Reinhardt D; Berdel D; Heimann G; Kusenbach G; von Berg A; Johnson E; Steinijans VW; Staudinger H
    Chronobiol Int; 1987; 4(3):369-80. PubMed ID: 3677217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a new sustained-release theophylline tablet for children.
    Selvig K; Alme A; Rugstad HE; Aas K; Bjerve KS
    Acta Paediatr Scand; 1981 Nov; 70(6):929-33. PubMed ID: 7324949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Food-induced "dose-dumping" from a once-a-day theophylline product as a cause of theophylline toxicity.
    Hendeles L; Weinberger M; Milavetz G; Hill M; Vaughan L
    Chest; 1985 Jun; 87(6):758-65. PubMed ID: 3996063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
    Steinijans VW; Zech K; Fischer R
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.